PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

New study compares provisional and two-stent strategies for coronary bifurcation lesions

Results of the Nordic-Baltic Bifurcation IV trial presented at TCT 2013

2013-10-31
(Press-News.org) Contact information: Judy Romero
jromero@crf.org
Cardiovascular Research Foundation
New study compares provisional and two-stent strategies for coronary bifurcation lesions Results of the Nordic-Baltic Bifurcation IV trial presented at TCT 2013 SAN FRANCISCO, CA – OCTOBER 30, 2013 – A new clinical trial shows that a two-stent technique for treatment of bifurcation lesions with a large stenotic side branch was not associated with significant improved outcomes compared to a provisional stenting approach. The findings from the Nordic-Baltic Bifurcation IV study were presented today at the 25th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. Sponsored by the Cardiovascular Research Foundation (CRF), TCT is the world's premier educational meeting specializing in interventional cardiovascular medicine.

Coronary bifurcation lesions are caused from a build-up of plaque in the heart at a location where one artery branches from another. In provisional side branch stenting, the main vessel branch is stented and the side branch only if compromised. Currently, provisional side branch stenting is the preferred strategy for treatment of bifurcation lesions.

The safety and effectiveness of provisional stenting for bifurcations that involve a large side branch of the coronary arteries is unknown. The Nordic-Baltic IV trial was a randomized, controlled, non-blinded, multicenter, superiority trial that compared provisional stenting with a two-stent strategy for the treatment of coronary bifurcation lesions involving a major side branch.

The primary endpoint was the composite of major adverse cardiac events (MACE) including cardiac death, non-procedure-related myocardial infarction, target vessel revascularization and stent thrombosis after six months. Follow up is planned until five years. A total of 450 patients with coronary bifurcation lesions were randomized 1:1 to the provisional strategy (stenting of the main vessel and provisional stenting of the side branch) or a complex two-stent strategy (planned stenting of both the main vessel and the side branch).

After six months, the MACE rate was not significantly different between provisional and two-stent techniques (4.6 percent and 1.8 percent, respectively, p=0.09). Individual endpoints were also similar between the two techniques including total death (0 and 0.4 percent, p=0.32), non-procedural myocardial infarction (1.8 percent and 0.9 percent, p=0.50) and target vessel revascularization (3.7 percent and 1.3 percent, p=0.11). There were no incidents of cardiac death in either group.

However, in contrast to prior studies, longer and more complex procedures in the two-stent group did not translate into more procedural myocardial infarctions.

"Results of this trial indicate that a two-stent technique does not significantly improve mid-term outcomes for patients with bifurcation lesions compared to provisional stenting," said lead investigator Indulis Kumsars, MD. Dr. Kumsars is Head of the Cardiac Catheterization Laboratory at the Latvian Cardiology Center in Riga, Latvia.

Given the fact that there was a weak trend towards lower MACE in the two stent strategy and follow up is continuing for five years, the Nordic-Baltic investigators concluded, "Recommendations on optimal strategies for this lesion subset should await longer term follow up."

###

The Nordic-Baltic Bifurcation IV study was an academic investigator trial conducted by the Nordic-Baltic PCI Study group. The study was funded by participating institutions and by unrestricted research grants from Abbott and Cordis. Dr. Kumsars reported no disclosures.

About CRF and TCT

The Cardiovascular Research Foundation (CRF) is an independent, academically focused nonprofit organization dedicated to improving the survival and quality of life for people with cardiovascular disease through research and education. Since its inception in 1991, CRF has played a major role in realizing dramatic improvements in the lives of countless numbers of patients by establishing the safe use of new technologies and therapies in interventional cardiovascular medicine. CRF is the sponsor of the Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. Celebrating its 25th anniversary this year, TCT is the world's premier educational meeting specializing in interventional cardiovascular medicine. For more information, visit http://www.crf.org and http://www.tctconference.com.

END



ELSE PRESS RELEASES FROM THIS DATE:

TGen-led research shows ability to do next-generation sequencing for patients with advanced cancers

2013-10-31
TGen-led research shows ability to do next-generation sequencing for patients with advanced cancers Faster analysis of genetic variations should uncover new drug targets and pathways even as cancers mutate beyond initial therapies SCOTTSDALE, ...

Stanford researchers show how universe's violent youth seeded cosmos with iron

2013-10-31
Stanford researchers show how universe's violent youth seeded cosmos with iron New evidence that iron is spread evenly between the galaxies in one of the largest galaxy clusters in the universe supports the theory that the universe underwent a turbulent and ...

Absence of the SMG1 protein could contribute to Parkinson's and other neurological disorders

2013-10-31
Absence of the SMG1 protein could contribute to Parkinson's and other neurological disorders TGen-led study links lack of SMG1 to protein aggregates associated with Parkinson's disease, forms of dementia and multiple systems atrophy PHOENIX, ...

New study analyzes barriers to cancer research commercialization

2013-10-31
New study analyzes barriers to cancer research commercialization LEXINGTON, Ky. (Oct. 30, 2013) — A new study led by the University of Kentucky Markey Cancer Center Assistant Director for Research Nathan Vanderford cites a combination of factors that prevent academic-based ...

Notre Dame research finding may help accelerate diabetic wound healing

2013-10-31
Notre Dame research finding may help accelerate diabetic wound healing University of Notre Dame researchers have, for the first time, identified the enzymes that are detrimental to diabetic wound healing and those that are beneficial to repair the wound. There are ...

Medical students taught meditation techniques to prevent burnout and improve care

2013-10-31
Medical students taught meditation techniques to prevent burnout and improve care WINSTON-SALEM, N.C., – Oct. 30, 2013 – Doctors commonly tell patients that stress can be harmful to their health. Yet when it comes to reducing their own stress levels, ...

The secret math of plants: UCLA biologists uncover rules that govern leaf design

2013-10-31
The secret math of plants: UCLA biologists uncover rules that govern leaf design Life scientists from UCLA's College of Letters and Science have discovered fundamental rules of leaf design that underlie plants' ability to produce leaves that ...

Old drug may teach new tricks in treating infectious diseases, cancer

2013-10-31
Old drug may teach new tricks in treating infectious diseases, cancer COLLEGE STATION – Meclizine, an over-the-counter drug used for decades to treat nausea and motion sickness, has the potential for new uses to treat certain infectious diseases ...

6-month data of the LEVANT 2 trial presented at TCT 2013

2013-10-31
6-month data of the LEVANT 2 trial presented at TCT 2013 New study examines safety and efficacy of drug coated baloon angioplasty for treatment of femoropopliteal artery disease SAN FRANCISCO, CA – October 30, 2013 – The first clinical trial in the United States to study ...

Procedural results from the RIBS V trial presented at TCT 2013

2013-10-31
Procedural results from the RIBS V trial presented at TCT 2013 Good outcomes with both drug-eluting stents and drug-eluting balloons in treating patients with bare metal stent restenosis SAN FRANCISCO, CA – October 30, 2013 – A clinical trial comparing the use of drug-eluting ...

LAST 30 PRESS RELEASES:

Youngest in class at higher risk of mental health problems

American Heart Association announces new volunteer leaders for 2025-26

Gut microbiota analysis can help catch gestational diabetes

FAU’s Paulina DeVito awarded prestigious NSF Graduate Research Fellowship

Champions for change – Paid time off initiative just made clinical trials participation easier

Fentanyl detection through packaging

Prof. Eran Meshorer elected to EMBO for pioneering work in epigenetics

New 3D glacier visualizations provide insights into a hotter Earth

Creativity across disciplines

Consequences of low Antarctic sea ice

Hear here: How loudness and acoustic cues help us judge where a speaker is facing

A unique method of rare-earth recycling can strengthen the raw material independence of Europe and America

Epilepsy self-management program shows promise to control seizures, improve mood and quality of life

Fat may play an important role in brain metabolism

New study finds no lasting impact of pandemic pet ownership on human well-being

New insights on genetic damage of some chemotherapies could guide future treatments with less harmful side effects

Gut microbes could protect us from toxic ‘forever chemicals’

Novel modelling links sea ice loss to Antarctic ice shelf calving events

Scientists can tell how fast you're aging from a single brain scan

U.S. uterine cancer incidence and mortality rates expected to significantly increase by 2050

Public take the lead in discovery of new exploding star

What are they vaping? Study reveals alarming surge in adolescent vaping of THC, CBD, and synthetic cannabinoids

ECMWF - delivering forecasts over 10 times faster and cutting energy usage by 1000

Brazilian neuroscientist reveals how viral infections transform the brain through microscopic detective work

Turning social fragmentation into action through discovering relatedness

Cheese may really be giving you nightmares, scientists find

Study reveals most common medical emergencies in schools

Breathable yet protective: Next-gen medical textiles with micro/nano networks

Frequency-engineered MXene supercapacitors enable efficient pulse charging in TENG–SC hybrid systems

Developed an AI-based classification system for facial pigmented lesions

[Press-News.org] New study compares provisional and two-stent strategies for coronary bifurcation lesions
Results of the Nordic-Baltic Bifurcation IV trial presented at TCT 2013